Hutchison China Meditech to Distribute AstraZeneca's Seroquel in China
January 29 2015 - 4:26AM
Dow Jones News
LONDON--Hutchison China Meditech Ltd. (HCM.LN) said Thursday its
subsidiary Hutchison Whampoa Sinopharm Pharmaceuticals (Shanghai)
Company Ltd., has entered into an exclusive agreement with
AstraZeneca (Wuxi) Trading Co., Ltd. to distribute and market
Seroquel(R), an antipsychotic prescription drug owned by
AstraZeneca PLC (AZN.LN), in China.
Chi-Med, a pharmaceutical and healthcare company based primarily
in China, didn't provide any financial details of the
agreement.
Hutchison China shares at 0950 GMT up 60 pence, or 4.26%, at
1470 pence valuing the company at 780 million pounds ($1.18
billion).
-Write to Ian Walker at ian.walker@wsj.com; @IanWalk40289749
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Astrazeneca (LSE:AZN)
Historical Stock Chart
From Apr 2024 to May 2024
Astrazeneca (LSE:AZN)
Historical Stock Chart
From May 2023 to May 2024